Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Apellis Pharmaceuticals Inc
(NQ:
APLS
)
47.53
+0.02 (+0.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,179,340
Open
47.52
Bid (Size)
47.53 (1)
Ask (Size)
49.50 (1)
Prev. Close
47.51
Today's Range
46.53 - 48.19
52wk Range
19.83 - 94.45
Shares Outstanding
116,457,008
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The 5 Stocks Most Sold By Insiders This Year
April 16, 2024
Insiders are selling these 5 stocks increased as their markets advanced, and gains may be capped. Long-term outlooks are positive for growth and share prices.
Via
MarketBeat
Expert Ratings For Apellis Pharmaceuticals
April 15, 2024
Via
Benzinga
Performance
YTD
-22.43%
-22.43%
1 Month
-14.39%
-14.39%
3 Month
-25.50%
-25.50%
6 Month
+2.44%
+2.44%
1 Year
-42.34%
-42.34%
More News
Read More
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,000 Today
April 10, 2024
Via
Benzinga
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 04, 2024
From
Apellis Pharmaceuticals, Inc.
Via
GlobeNewswire
$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,000 Today
March 29, 2024
Via
Benzinga
Decoding 15 Analyst Evaluations For Apellis Pharmaceuticals
March 27, 2024
Via
Benzinga
Peering Into Apellis Pharmaceuticals's Recent Short Interest
March 15, 2024
Via
Benzinga
Deep Dive Into Apellis Pharmaceuticals Stock: Analyst Perspectives (18 Ratings)
February 28, 2024
Via
Benzinga
Apellis Pharmaceuticals to Host a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
April 01, 2024
From
Apellis Pharmaceuticals, Inc.
Via
GlobeNewswire
Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor
March 11, 2024
From
Apellis Pharmaceuticals, Inc.
Via
GlobeNewswire
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 06, 2024
From
Apellis Pharmaceuticals, Inc.
Via
GlobeNewswire
Earnings Scheduled For February 27, 2024
February 27, 2024
Via
Benzinga
Here's How Much You Would Have Made Owning Apellis Pharmaceuticals Stock In The Last 5 Years
February 22, 2024
Via
Benzinga
$1000 Invested In Apellis Pharmaceuticals 5 Years Ago Would Be Worth This Much Today
February 05, 2024
Via
Benzinga
Critical Insights From Apellis Pharmaceuticals Analyst Ratings: What You Need To Know
January 30, 2024
Via
Benzinga
Beam Therapeutics Bolts Higher on Gene Therapy Licensing Payments
March 06, 2024
Via
MarketBeat
ICU Medical To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday
February 28, 2024
Via
Benzinga
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
February 27, 2024
From
Apellis Pharmaceuticals, Inc.
Via
GlobeNewswire
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
February 26, 2024
From
Apellis Pharmaceuticals, Inc.
Via
GlobeNewswire
Apellis Pharmaceuticals to Host Conference Call on February 27, 2024, to Discuss Fourth Quarter and Full Year 2023 Financial Results
February 20, 2024
From
Apellis Pharmaceuticals, Inc.
Via
GlobeNewswire
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 06, 2024
From
Apellis Pharmaceuticals, Inc.
Via
GlobeNewswire
Pinterest To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Monday
February 05, 2024
Via
Benzinga
Apellis Announces Negative CHMP Opinion for Pegcetacoplan for GA in the European Union and Plans to Seek Re-Examination of Application
January 26, 2024
From
Apellis Pharmaceuticals, Inc.
Via
GlobeNewswire
Netflix To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
January 24, 2024
Via
Benzinga
Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday
January 17, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.